Is Zebra Technologies (ZBRA) Offering Opportunity After Recent Share Price Volatility?

  • If you are wondering whether Zebra Technologies at around US$256.57 is a bargain or a value trap, you are not alone, as the share price and the fundamentals are sending some very mixed signals.
  • Over the past week the stock is up 10%, yet the 30 day return is a 1.1% decline and the longer term record shows returns of 3.3% year to date, a 27.6% decline over 1 year and a 47.2% decline over 5 years.
  • Recent coverage has focused on how investors are reassessing hardware focused tech names like Zebra Technologies, especially those tied to barcoding, scanning and data capture across retail and industrial supply chains. That context helps explain why the share price has been volatile as the market weighs long term demand for these solutions against earlier enthusiasm that is no longer reflected in the 1 year and 5 year return numbers.
  • Zebra Technologies currently scores a 6 out of 6 on our valuation checks. This suggests it screens as undervalued across all six methods we use. Next we will walk through what those approaches say about the stock today and then finish with a more complete way to think about valuation that goes beyond any single model.

Find out why Zebra Technologies's -27.6% return over the last year is lagging behind its peers.

Advertisement

Approach 1: Zebra Technologies Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model takes the cash Zebra Technologies is expected to generate in the future, then discounts those projections back to a single value in today's dollars. That gives an estimate of what the business could be worth based purely on cash generation.

For Zebra, the model uses a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is about $786.8 million. Analysts provide forecasts out to 2029, with projected free cash flow of $1,059 million in that year, and Simply Wall St extrapolates additional years beyond the formal analyst horizon using modest growth assumptions.

Discounting these projected cash flows back to today produces an estimated intrinsic value of about $329.83 per share. Compared with a recent share price around $256.57, the DCF output implies the stock trades at roughly a 22.2% discount, which screens as undervalued on this model.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Zebra Technologies is undervalued by 22.2%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

ZBRA Discounted Cash Flow as at Feb 2026
ZBRA Discounted Cash Flow as at Feb 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Zebra Technologies.

Approach 2: Zebra Technologies Price vs Earnings

For a profitable company like Zebra Technologies, the P/E ratio is a useful way to see how much you are paying for each dollar of current earnings. Investors often accept a higher P/E when they expect stronger growth or see lower risk, and look for a lower P/E when they are cautious about growth or see more risk.

Zebra currently trades on a P/E of 25.39x. That sits slightly below the Electronic industry average of 26.85x and well below the peer group average of 47.11x, which suggests the market is valuing Zebra at a discount to many comparable names on earnings.

Simply Wall St also calculates a Fair Ratio for Zebra of 30.52x. This is a proprietary estimate of what the P/E might be, given factors such as earnings growth, profit margins, the Electronic industry context, company size and specific risks. Because it blends these company specific inputs, the Fair Ratio can give a more tailored reference point than a simple comparison with peers or the broad industry, which may include businesses with very different profiles.

Comparing Zebra’s current P/E of 25.39x with the Fair Ratio of 30.52x suggests the shares are screening as undervalued on this metric.

Result: UNDERVALUED

NasdaqGS:ZBRA P/E Ratio as at Feb 2026
NasdaqGS:ZBRA P/E Ratio as at Feb 2026

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 23 top founder-led companies.

Upgrade Your Decision Making: Choose your Zebra Technologies Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, a simple way for you to write the story you believe about Zebra Technologies, link that story to a forecast for revenue, earnings and margins, and then see what fair value drops out on Simply Wall St's Community page, where millions of investors share and compare their views.

In practice, a Narrative connects three pieces: the business story you believe, the financial forecasts that follow from that story, and the fair value that those numbers imply. You can then compare this with the current share price to help you decide whether the stock looks attractive or stretched at any point in time.

Because Narratives on Simply Wall St update automatically when new data such as news or earnings arrives, you are not locked into a single view. You can see how your fair value moves relative to others, including investors who think Zebra could be worth closer to US$400 per share and more cautious investors who see fair value nearer to US$263 per share, all using different but transparent assumptions about the same business.

Do you think there's more to the story for Zebra Technologies? Head over to our Community to see what others are saying!

NasdaqGS:ZBRA 1-Year Stock Price Chart
NasdaqGS:ZBRA 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Zebra Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:ZBRA

Zebra Technologies

Operates in the automatic identification and data capture solutions industry worldwide.

Undervalued with moderate growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
49 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7720.1% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9217.2% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1907.4% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

FE
PASS3 logo
FernandoLeal on Compass Gas e Energia ·

Compass Gas e Energia has a reliable dividend, with a consistent moat, high free cash flow margins and will expand to two digits net margin.

Fair Value:R$40.9439.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BR
Brunhilde_Wagner
CPRT logo
Brunhilde_Wagner on Copart ·

Compounder to Cash Generator in Real Time

Fair Value:US$2710.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.9% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
84 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
192 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
AN
CSMG3 logo
andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

Gostei

0
|
0